Ardent Health Partners
Stock Forecast, Prediction & Price Target
Ardent Health Partners (ARDT) stock Price Target by analysts
Ardent Health Partners (ARDT) stock Price Target by analysts
Average Price Target
$24
Potential upside: 87.49%
Ardent Health Partners price prediction
What is Ardent Health Partners stock analysts` prediction?
Ardent Health Partners stock forecast: Based on 1 Wall Street analysts` predicted price targets for Ardent Health Partners in the last 3 months, the avarage price target is $24, with a high forecast of $NaN. The average price target represents a 87.49% change from the last price of $12.8.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Ardent Health Partners stock Price Target by analysts
Full breakdown of analysts given Ardent Health Partners price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Matthew Gillmor KeyBanc | 0% 0/1 | 12 months ago | $24 87.49% upside | $18.12 | TheFly | Previous targets (0) |
Scott Fidel Stephens | 0% 0/1 | about 1 year ago | $24 87.49% upside | $17.21 | StreetInsider | Previous targets (0) |
David MacDonald Truist Financial | 0% 0/2 | about 1 year ago | $22 71.87% upside | $16.97 | TheFly | Previous targets (1) |
Timothy Greaves Loop Capital Markets | 0% 0/1 | about 1 year ago | $21 64.06% upside | $16.97 | TheFly | Previous targets (0) |
Ann Hynes Mizuho Securities | 0% 0/1 | about 1 year ago | $20 56.24% upside | $15.64 | TheFly | Previous targets (0) |
Craig Hettenbach Morgan Stanley | 0% 0/1 | about 1 year ago | $27 110.93% upside | $15.64 | TheFly | Previous targets (0) |
David MacDonald Truist Financial | 0% 0/2 | about 1 year ago | $21 64.06% upside | $15.64 | TheFly | Previous targets (1) |
FAQ
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Ardent Health Partners stock. The most successful analyst is Matthew Gillmor.